Trial Profile
A Randomized, Double-Blind, Placebo- and Moxifloxacin (Open-Label)-Controlled, 4-Period Crossover Study of the Effects of a Single Dose of MOA-728 Infused Intravenously on Cardiac Repolarization in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 May 2019
Price :
$35
*
At a glance
- Drugs Methylnaltrexone bromide (Primary) ; Moxifloxacin
- Indications Bacterial infections; Constipation
- Focus Adverse reactions
- Sponsors Bausch Health Companies; Wyeth
- 01 Aug 2011 New trial record